{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:04:12Z","timestamp":1755223452290,"version":"3.43.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89836","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T21:43:32Z","timestamp":1754948612000},"source":"Crossref","is-referenced-by-count":0,"title":["Annular Erythema in a Nine-Year-Old Girl: A Rare Type of Psoriasis"],"prefix":"10.7759","author":[{"given":"Maho","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.12.007","article-title":"Papulosquamous annular diseases","volume":"40","author":"Aslan Kay\u0131ran M","year":"2022","unstructured":"Aslan Kay\u0131ran M, Wang JV, Karadag AS. Papulosquamous annular diseases. Clin Dermatol. 2022, 40:441-9. 10.1016\/j.clindermatol.2021.12.007","journal-title":"Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17643","article-title":"Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database","volume":"52","author":"Ma Y","year":"2025","unstructured":"Ma Y, Chachin M, Hirose T, Nakamura K, Shi N, Hiro S, Imafuku S. Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database. J Dermatol. 2025, 52:841-54. 10.1111\/1346-8138.17643","journal-title":"J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths CEM","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021, 397:1301-15. 10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003590","article-title":"Annular pustular psoriasis: a heterogeneous subtype of generalized pustular psoriasis","volume":"138","author":"Wu X","year":"2025","unstructured":"Wu X, Han C, Li Z, Zhang Z. Annular pustular psoriasis: a heterogeneous subtype of generalized pustular psoriasis. Chin Med J (Engl). 2025, 138:1630-2. 10.1097\/CM9.0000000000003590","journal-title":"Chin Med J (Engl)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15976","article-title":"Case of annular pustular psoriasis\/circinate erythematous psoriasis induced by hydroxychloroquine in a patient with systemic lupus erythematosus: possible association with CARD-14 mutation","volume":"48","author":"Midorikawa H","year":"2021","unstructured":"Midorikawa H, Kiniwa Y, Minagawa A, et al.. Case of annular pustular psoriasis\/circinate erythematous psoriasis induced by hydroxychloroquine in a patient with systemic lupus erythematosus: possible association with CARD-14 mutation. J Dermatol. 2021, 48:e440-2. 10.1111\/1346-8138.15976","journal-title":"J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2005.22103.x","article-title":"Primary annular plaque-type psoriasis","volume":"22","author":"Guill CL","year":"2005","unstructured":"Guill CL, Hoang MP, Carder KR. Primary annular plaque-type psoriasis. Pediatr Dermatol. 2005, 22:15-8. 10.1111\/j.1525-1470.2005.22103.x","journal-title":"Pediatr Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1981.","article-title":"Annular pustular psoriasis","volume":"117","author":"Adler DJ","year":"1981","unstructured":"Adler DJ, Rower JM, Hashimoto K. Annular pustular psoriasis. Arch Dermatol. 1981, 117:313-4. 10.1001\/archderm.1981.","journal-title":"Arch Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb JE","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, et al.. Psoriasis. Nat Rev Dis Primers. 2016, 2:16082. 10.1038\/nrdp.2016.82","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.05.019","article-title":"Autoinflammatory keratinization diseases","volume":"140","author":"Akiyama M","year":"2017","unstructured":"Akiyama M, Takeichi T, McGrath JA, Sugiura K. Autoinflammatory keratinization diseases. J Allergy Clin Immunol. 2017, 140:1545-7. 10.1016\/j.jaci.2017.05.019","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15840","article-title":"Psoriasis: comorbidities","volume":"48","author":"Yamazaki F","year":"2021","unstructured":"Yamazaki F. Psoriasis: comorbidities. J Dermatol. 2021, 48:732-40. 10.1111\/1346-8138.15840","journal-title":"J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke WH","year":"2018","unstructured":"Boehncke WH. Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences. Front Immunol. 2018, 9:579. 10.3389\/fimmu.2018.00579","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17002","article-title":"Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial","volume":"35","author":"Bodemer C","year":"2021","unstructured":"Bodemer C, Kaszuba A, Kingo K, et al.. Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial. J Eur Acad Dermatol Venereol. 2021, 35:938-47. 10.1111\/jdv.17002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00501-6","article-title":"Effectiveness and safety of adalimumab, etanercept and ustekinumab for severe psoriasis in children under 12 years of age: a French-Italian daily practice cohort (BiPe Jr)","volume":"24","author":"Zitouni J","year":"2022","unstructured":"Zitouni J, Beauchet A, Curmin R, et al.. Effectiveness and safety of adalimumab, etanercept and ustekinumab for severe psoriasis in children under 12 years of age: a French-Italian daily practice cohort (BiPe Jr). Paediatr Drugs. 2022, 24:281-92. 10.1007\/s40272-022-00501-6","journal-title":"Paediatr Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399706-annular-erythema-in-a-nine-year-old-girl-a-rare-type-of-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T21:43:33Z","timestamp":1754948613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399706-annular-erythema-in-a-nine-year-old-girl-a-rare-type-of-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.89836","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}